Selected article for: "bivalent vaccine and influenza bivalent vaccine"

Author: Shehata, Mahmoud M.; Kandeil, Ahmed; Mostafa, Ahmed; Mahmoud, Sara H.; Gomaa, Mokhtar R.; El-Shesheny, Rabeh; Webby, Richard; Kayali, Ghazi; A. Ali, Mohamed
Title: A Recombinant Influenza A/H1N1 Carrying A Short Immunogenic Peptide of MERS-CoV as Bivalent Vaccine in BALB/c Mice
  • Document date: 2019_12_2
  • ID: 15q6qr4z_4
    Snippet: Due to the well-studied safety profile of IAVs and their easy propagation and production using either embryonated chicken eggs or cell culture systems, several studies have used recombinant IAVs to either express certain immune modulators and anticancer proteins to combat cancer cells (oncolytic virus) [13, 14] . Yang et al. (2014) , synthesized short peptide 25 amino acid (aa) residues from spike protein of MERS-CoV at position 736-761 (CALPDTPS.....
    Document: Due to the well-studied safety profile of IAVs and their easy propagation and production using either embryonated chicken eggs or cell culture systems, several studies have used recombinant IAVs to either express certain immune modulators and anticancer proteins to combat cancer cells (oncolytic virus) [13, 14] . Yang et al. (2014) , synthesized short peptide 25 amino acid (aa) residues from spike protein of MERS-CoV at position 736-761 (CALPDTPSTLTPRSVRSVPGEMRLA), which elicited nAbs in mice and rabbits against MERS-CoV [15] . Herein, we used a recombinant influenza A H1N1pdm09pandemic (A/California/04/2009) as a PR8-based vector to express an immunogenic short peptide residue of the spike protein of MERS-CoV elicited immunity against MERS-CoV and H1N1pdm09. This short peptide was inserted in the neuraminidase gene of A/California/04/2009 (H1N1) for production of a PR8-based bivalent vaccine against influenza and MERS-CoV.

    Search related documents:
    Co phrase search for related documents
    • amino acid and cancer cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • amino acid and cell culture: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • amino acid and cell culture system: 1, 2, 3, 4, 5, 6, 7, 8
    • amino acid and chicken egg: 1, 2, 3, 4
    • amino acid and elicit immunity: 1, 2, 3
    • amino acid and H1N1 neuraminidase gene: 1
    • amino acid and immune modulator: 1, 2
    • amino acid and MERS CoV spike protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • bivalent vaccine and cell culture: 1
    • bivalent vaccine and elicit immunity: 1
    • bivalent vaccine and MERS CoV spike protein: 1
    • bivalent vaccine and MERS influenza bivalent vaccine: 1, 2
    • cancer cell and cell culture: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cancer cell and cell culture system: 1
    • cell culture and chicken egg: 1, 2
    • cell culture and elicit immunity: 1, 2, 3
    • cell culture and immune modulator: 1
    • cell culture and MERS CoV spike protein: 1
    • cell culture system and elicit immunity: 1